• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION. INC. WEB SL; INTRASACCULAR FLOW DISRUPTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION. INC. WEB SL; INTRASACCULAR FLOW DISRUPTION DEVICE Back to Search Results
Model Number W5-3.5-2-MVI
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Paralysis (1997); Vasoconstriction (2126); Speech Disorder (4415)
Event Date 09/03/2022
Event Type  Injury  
Manufacturer Narrative
A search for non-conformances associated with the reported part/lot number combination did not reveal any production-related issues relevant to the complaint, that occurred during manufacturing of the device.The device was implanted in the patient and is not available to return to the manufacturer for analysis, and procedure images were not provided.Therefore, the alleged product issue cannot be confirmed.If additional information is received, microvention, inc.Will submit a supplemental report.The instructions for use (ifu) identifies vasospasm, headache, and neurologic deficits as potential complications associated with use of the device.
 
Event Description
It was reported that the web device was successfully implanted on (b)(6) 2022 to treat a subarachnoid hemorrhage (sah), anterior communicating artery (acom) aneurysm.During hospital stay, vasospasm on the left side occurred, which was treated with antispasmodics.The patient was discharged with light motoric aphasia.Reportedly, 1-2 weeks post procedure, the patient's condition worsened with progressive aphasia, right side hemiparesis, headache, and hypertonia.In the hospital, progressive cerebral enrichment was administered for suspected nice (non-ischemic cerebral enhancing).Treatment with methylprednisolone showed significant improvement.Currently, the patient's condition was described as progressive symptoms during lowering of the prednisolone dose.The patient is put on follow-up.
 
Manufacturer Narrative
Additional information received indicating no pre-existing conditions known which led to current patient condition.Unknown if patient was compliant with any dapt medicines post procedure.
 
Manufacturer Narrative
Additional information: h10 (image review).Four images were supplied.All four are from the same projection of an oblique left ica angiogram and are not dated.There are no measurements.Three are at different arterial phases of the subtracted dsa, and one has the superimposed bony background.They show a web in an occluded acom aneurysm; the web is adequately positioned.There are no images of the aneurysm before treatment.There are mild irregularities of the left a1, acom, and of the proximal bilateral a2s - these are in keeping with mild vasospasm secondary to the sah.There are no images that demonstrate the more severe vasospasm that is described to have occurred later on.The vasospasm on these images and the vasospasm that occurred subsequently are not related to the web procedure but rather to the sah, which is a known common cause of vasospasm.Without the return and physical evaluation of the device, the investigation cannot determine if a condition exists that would have caused or contributed to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WEB SL
Type of Device
INTRASACCULAR FLOW DISRUPTION DEVICE
Manufacturer (Section D)
MICROVENTION. INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key15906404
MDR Text Key304717182
Report Number2032493-2022-00539
Device Sequence Number1
Product Code OPR
UDI-Device Identifier00842429102039
UDI-Public(01)00842429102039(11)220328(17)270228(10)0000171932
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P170032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/18/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/02/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberW5-3.5-2-MVI
Device Lot Number0000171932
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/09/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-